Health Systems Research Institute,Thailand
9
3
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
11%
1 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
Role: collaborator
Exploring Different Dose-frequency Home Photodynamic Therapy Protocols Using a Novel Home-targeted LED Device for Onychomycosis
Role: collaborator
Multi-centred Clinico-genetic Study of Actinic Prurigo in Thailand
Role: collaborator
COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2
Role: collaborator
Investigating Neurocognitive Disorders Epidemiology
Role: collaborator
The Effectiveness of Intermittent Fasting and Behavioral Economics Intervention on Weight Control in Obese Patients
Role: collaborator
Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand
Role: collaborator
Implementation of an Integrated System of Artificial Intelligence and Referral Tracking for Real-time Diabetic Retinopathy Screening
Role: collaborator
Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection
Role: collaborator
All 9 trials loaded